BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND WIF1, WIF-1, 11197, ENSG00000156076 AND Diagnosis
5 results:

  • 1. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating wif1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma.
    Liu X; Shan W; Li T; Gao X; Kong F; You H; Kong D; Qiao S; Tang R
    BMC Cancer; 2021 Nov; 21(1):1224. PubMed ID: 34775955
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
    Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.
    Zhang C; Li J; Huang T; Duan S; Dai D; Jiang D; Sui X; Li D; Chen Y; Ding F; Huang C; Chen G; Wang K
    Oncotarget; 2016 Dec; 7(49):81255-81267. PubMed ID: 27835605
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.
    Pez F; Lopez A; Kim M; Wands JR; Caron de Fromentel C; Merle P
    J Hepatol; 2013 Nov; 59(5):1107-17. PubMed ID: 23835194
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Promoter methylation and mRNA expression of DKK-3 and wif-1 in hepatocellular carcinoma.
    Ding Z; Qian YB; Zhu LX; Xiong QR
    World J Gastroenterol; 2009 Jun; 15(21):2595-601. PubMed ID: 19496188
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.